1073TiP A phase I, first-in-human, multicenter, open-label, dose-escalation study of IPH5201 as monotherapy or in combination with durvalumab ± oleclumab in advanced solid tumours.
Saved in:
| Title: | 1073TiP A phase I, first-in-human, multicenter, open-label, dose-escalation study of IPH5201 as monotherapy or in combination with durvalumab ± oleclumab in advanced solid tumours. |
|---|---|
| Authors: | Powderly, J.1 (AUTHOR), Bendell, J.C.2 (AUTHOR), Carneiro, B.A.3 (AUTHOR), Italiano, A.4 (AUTHOR), Mercadé, T. Macarulla5 (AUTHOR), Alvarez, E. Castanon6 (AUTHOR), Imbimbo, M.7 (AUTHOR), Massard, C.8 (AUTHOR), Mueller, N.9 (AUTHOR), Gascó -Hernandez, A.9 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS728-S729. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152695727 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1073TiP A phase I, first-in-human, multicenter, open-label, dose-escalation study of IPH5201 as monotherapy or in combination with durvalumab ± oleclumab in advanced solid tumours. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Powderly%2C+J%2E%22">Powderly, J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bendell%2C+J%2EC%2E%22">Bendell, J.C.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Carneiro%2C+B%2EA%2E%22">Carneiro, B.A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Italiano%2C+A%2E%22">Italiano, A.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mercadé%2C+T%2E+Macarulla%22">Mercadé, T. Macarulla</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alvarez%2C+E%2E+Castanon%22">Alvarez, E. Castanon</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Imbimbo%2C+M%2E%22">Imbimbo, M.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Massard%2C+C%2E%22">Massard, C.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mueller%2C+N%2E%22">Mueller, N.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gascó+-Hernandez%2C+A%2E%22">Gascó -Hernandez, A.</searchLink><relatesTo>9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 4, Vol. 31, pS728-S729. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152695727 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2020.08.1193 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S728 Titles: – TitleFull: 1073TiP A phase I, first-in-human, multicenter, open-label, dose-escalation study of IPH5201 as monotherapy or in combination with durvalumab ± oleclumab in advanced solid tumours. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Powderly, J. – PersonEntity: Name: NameFull: Bendell, J.C. – PersonEntity: Name: NameFull: Carneiro, B.A. – PersonEntity: Name: NameFull: Italiano, A. – PersonEntity: Name: NameFull: Mercadé, T. Macarulla – PersonEntity: Name: NameFull: Alvarez, E. Castanon – PersonEntity: Name: NameFull: Imbimbo, M. – PersonEntity: Name: NameFull: Massard, C. – PersonEntity: Name: NameFull: Mueller, N. – PersonEntity: Name: NameFull: Gascó -Hernandez, A. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2020 Supplement 4 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 31 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |